FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1838074997> ?p ?o ?g. }

• W1838074997 endingPage "1586" @default.
• W1838074997 startingPage "1579" @default.
• W1838074997 abstract "Oral pulse therapy with vitamin D is effective in suppressing parathyroid hormone (PTH) secretion in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism (2'hpt). However, this treatment often leads to hypercalcemia. The goals of the study were: (1) to examine whether the incidence of hypercalcemia decreases when dialysate calcium is reduced from 1.25 to 1.0 mmol/L; (2) to determine the relative role of the factors involved in the pathogenesis of hypercalcemia; and (3) to study the efficacy of a low oral pulse dose of alfacalcidol in preventing the recurrence of 2'hpt. Fourteen continuous ambulatory peritoneal dialysis patients with 2'hpt were treated with pulse oral alfacalcidol and calcium carbonate and dialyzed with a 1.0-mmol (n = 7) or a 1.25-mmol (n = 7) dialysate calcium. The response rate (87%) and the incidence (71%) and severity of hypercalcemia were similar in both groups. In the early response stage, PTH decreased by 70% in both groups, and serum ionized calcium (iCa) increased from 1.18 +/- 0.02 to 1.27 +/- 0.04 mmol/L (P < 0.005) in the 1.0 group and from 1.19 +/- 0.02 to 1.29 +/- 0.02 mmol/L in the 1.25 group (P < 0.005). Nine of the 12 responders had a further decrease in serum PTH, which was associated with an additional increase in iCa from 1.28 +/- 0.02 to 1.47 +/- 0.04 (P < 0.005). Multivariate analysis showed that the early increase in iCa was positively correlated with alfacalcidol dosage (r = 0.69). In contrast, the late increase in iCa was mostly accounted for by the decrease in serum PTH (r = -0.93). This occurred while calcium carbonate, alfacalcidol dosage, and serum 1,25 hydroxy D3 remained unchanged compared with the early response stage. Finally, an alfacalcidol dose of 1 microg twice weekly was unable to maintain serum PTH at an adequate level in the long term. These data show that a reduction in dialysate calcium from 1.25 to 1.0 mmol does not reduce the occurrence of hypercalcemia and suggest that lowering serum PTH reduces the ability of the bone to handle a calcium load within a few weeks, thus causing hypercalcemia." @default.
• W1838074997 created "2016-06-24" @default.
• W1838074997 creator A5007572029 @default.
• W1838074997 creator A5012281845 @default.
• W1838074997 creator A5022769025 @default.
• W1838074997 creator A5025103974 @default.
• W1838074997 creator A5025539765 @default.
• W1838074997 creator A5060849682 @default.
• W1838074997 creator A5068511854 @default.
• W1838074997 creator A5088962354 @default.
• W1838074997 date "1997-10-01" @default.
• W1838074997 modified "2023-09-24" @default.
• W1838074997 title "Hypercalcemia during pulse vitamin D3 therapy in CAPD patients treated with low calcium dialysate" @default.
• W1838074997 cites W112394560 @default.
• W1838074997 cites W1963633537 @default.
• W1838074997 cites W1966348870 @default.
• W1838074997 cites W1970131674 @default.
• W1838074997 cites W1970659430 @default.
• W1838074997 cites W1999778136 @default.
• W1838074997 cites W2001480762 @default.
• W1838074997 cites W2006344193 @default.
• W1838074997 cites W2017940864 @default.
• W1838074997 cites W2018429484 @default.
• W1838074997 cites W2019678067 @default.
• W1838074997 cites W2025944409 @default.
• W1838074997 cites W2040447463 @default.
• W1838074997 cites W2044458288 @default.
• W1838074997 cites W2055923382 @default.
• W1838074997 cites W2063238448 @default.
• W1838074997 cites W2076657386 @default.
• W1838074997 cites W2079984725 @default.
• W1838074997 cites W2093769583 @default.
• W1838074997 cites W2094803889 @default.
• W1838074997 cites W2113219485 @default.
• W1838074997 cites W2167999248 @default.
• W1838074997 cites W2271295507 @default.
• W1838074997 cites W2271794555 @default.
• W1838074997 cites W2307744392 @default.
• W1838074997 cites W2338493548 @default.
• W1838074997 cites W2372597635 @default.
• W1838074997 cites W2409809459 @default.
• W1838074997 cites W2410484974 @default.
• W1838074997 cites W2430967179 @default.
• W1838074997 cites W2469920577 @default.
• W1838074997 doi "https://doi.org/10.1681/asn.v8101579" @default.
• W1838074997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9335387" @default.
• W1838074997 hasPublicationYear "1997" @default.
• W1838074997 type Work @default.
• W1838074997 sameAs 1838074997 @default.
• W1838074997 citedByCount "8" @default.
• W1838074997 countsByYear W18380749972014 @default.
• W1838074997 crossrefType "journal-article" @default.
• W1838074997 hasAuthorship W1838074997A5007572029 @default.
• W1838074997 hasAuthorship W1838074997A5012281845 @default.
• W1838074997 hasAuthorship W1838074997A5022769025 @default.
• W1838074997 hasAuthorship W1838074997A5025103974 @default.
• W1838074997 hasAuthorship W1838074997A5025539765 @default.
• W1838074997 hasAuthorship W1838074997A5060849682 @default.
• W1838074997 hasAuthorship W1838074997A5068511854 @default.
• W1838074997 hasAuthorship W1838074997A5088962354 @default.
• W1838074997 hasBestOaLocation W18380749971 @default.
• W1838074997 hasConcept C124490489 @default.
• W1838074997 hasConcept C126322002 @default.
• W1838074997 hasConcept C126894567 @default.
• W1838074997 hasConcept C134018914 @default.
• W1838074997 hasConcept C2776079296 @default.
• W1838074997 hasConcept C2776940978 @default.
• W1838074997 hasConcept C2779056158 @default.
• W1838074997 hasConcept C2781208988 @default.
• W1838074997 hasConcept C3020581077 @default.
• W1838074997 hasConcept C519063684 @default.
• W1838074997 hasConcept C71924100 @default.
• W1838074997 hasConceptScore W1838074997C124490489 @default.
• W1838074997 hasConceptScore W1838074997C126322002 @default.
• W1838074997 hasConceptScore W1838074997C126894567 @default.
• W1838074997 hasConceptScore W1838074997C134018914 @default.
• W1838074997 hasConceptScore W1838074997C2776079296 @default.
• W1838074997 hasConceptScore W1838074997C2776940978 @default.
• W1838074997 hasConceptScore W1838074997C2779056158 @default.
• W1838074997 hasConceptScore W1838074997C2781208988 @default.
• W1838074997 hasConceptScore W1838074997C3020581077 @default.
• W1838074997 hasConceptScore W1838074997C519063684 @default.
• W1838074997 hasConceptScore W1838074997C71924100 @default.
• W1838074997 hasIssue "10" @default.
• W1838074997 hasLocation W18380749971 @default.
• W1838074997 hasOpenAccess W1838074997 @default.
• W1838074997 hasPrimaryLocation W18380749971 @default.
• W1838074997 hasRelatedWork W1974087872 @default.
• W1838074997 hasRelatedWork W1990422519 @default.
• W1838074997 hasRelatedWork W1999545086 @default.
• W1838074997 hasRelatedWork W2012020043 @default.
• W1838074997 hasRelatedWork W2013152947 @default.
• W1838074997 hasRelatedWork W2064236298 @default.
• W1838074997 hasRelatedWork W2067836013 @default.
• W1838074997 hasRelatedWork W2107762597 @default.
• W1838074997 hasRelatedWork W2127828880 @default.
• W1838074997 hasRelatedWork W2162385374 @default.
• W1838074997 hasVolume "8" @default.

• next